Skip to NavigationSkip to content
Worker protest
Staff take to the streets over decision to shut Verona R&D facility
Dr Philipp Rosler
Philipp Rösler says industry has a monopolistic hold over the country
Bristol-Myers Squibb and AstraZeneca prepare phase IV trial for their diabetes treatment
Gains MS and cancer candidates through Facet Biotech deal
Penknife

To assemble an orphan and rare disease marketing brand you’ll need a versatile toolkit, says MSI’s Michael Craig

a site by SiftGroups